Blood Test to Screen for Pancreatic Cancer During Health Checkups in Japan
Tests a blood test for finding pancreatic cancer in adults without symptoms.
Plain-language title generated from the registry record
Registry title: Pancreatic Cancer Screening Using the Enzeavour Assay in Japan
Key facts
- Where
- Atsugi, Chiba, Chuo-ku, Fukuoka, Gobō, Hamamatsu, Hiroshima, Iida, Isehara, Kasamatsuchō, Kawasaki, Kita-gun Miki-cho, Kobe, Kochi, Koganei, Kurashiki, Kyoto, Matsusaka, Mibu, Minato-ku, Minato-Ku, Mito, Nagakute, Nagoya, Obihiro, Okayama, Okinawa, Onomichi, Osaka, Ōtsu, Sagamihara, Saitama, Sapporo, Shimajiri-gun Haebaru-cho, Shinjuku-ku, tabashi City, Takamatsu, Tsu, Wakayama, Yamagata, Yokohama, and Yufu, JapanSee the 69 sites
Where in Japan
- JA Health Management Center AtsugiAtsugi, JapanTaking people
- Chiba University HospitalChiba, JapanTaking people
- Medical Check Studio Tokyo Ginza ClinicChuo-ku, JapanTaking people
- Fukuoka University HospitalFukuoka, JapanTaking people
- Wellness TenjinFukuoka, JapanTaking people
- Health Checkup Center KitadeGobō, JapanTaking people
- Seirei Hamamatsu General HospitalHamamatsu, JapanTaking people
- Seirei Preventive Health Care CenterHamamatsu, JapanTaking people
- Hiroshima University HospitalHiroshima, JapanTaking people
- Iida Municipal HospitalIida, JapanTaking people
- Isehara Kyodo HospitalIsehara, JapanTaking people
- Matsunami General HospitalKasamatsuchō, JapanTaking people
- St. Marianna University School of Medicine HospitalKawasaki, JapanTaking people
- Kagawa University HospitalKita-gun Miki-cho, JapanTaking people
- Hotel Okura Kobe ClinicKobe, JapanTaking people
- Kobe University HospitalKobe, JapanTaking people
- Sano HospitalKobe, JapanTaking people
- Clinic Green HouseKochi, JapanTaking people
- Japanese RedCross Society Kochi Red Cross HospitalKochi, JapanTaking people
- Kochi Kenshin ClinicKochi, JapanTaking people
- Koganei Tsurukame ClinicKoganei, JapanTaking people
- Junpukai Health Maintenance Center KurashikiKurashiki, JapanTaking people
- Kawasaki Medical School General Medical CenterKurashiki, JapanTaking people
- Kyoto Industrial Health AssociationKyoto, JapanTaking people
- Kyoto University HospitalKyoto, JapanTaking people
- Mitsubishi Kyoto HospitalKyoto, JapanTaking people
- Matsusaka Chuo General HospitalMatsusaka, JapanTaking people
- Matsusaka Medical AssociationMatsusaka, JapanTaking people
- Dokkyo Medical University HospitalMibu, JapanTaking people
- The Jikei University HospitalMinato-ku, JapanTaking people
- C'est la vie Shinbashi ClinicMinato-Ku, JapanTaking people
- Ibaraki Medical CenterMito, JapanTaking people
- Mito Kyodo General HospitalMito, JapanTaking people
- Aichi Medical University HospitalNagakute, JapanTaking people
- Chunichi HospitalNagoya, JapanTaking people
- Nagoya University HospitalNagoya, JapanTaking people
- Obihiro Kosei HospitalObihiro, JapanTaking people
- Junpukai Health Maintenance CenterOkayama, JapanTaking people
- Junpukai Health Maintenance Center DaianjiOkayama, JapanTaking people
- Nakagami General Chibana ClinicOkinawa, JapanTaking people
- Nakagami HospitalOkinawa, JapanTaking people
- JA Onomichi General HospitalOnomichi, JapanTaking people
- Medical Research Institute KITANO HOSPITAL,PIIF Tazuke-KofukaiOsaka, JapanTaking people
- NEO Healthcare GI Endoscopy Clinic HonmachiOsaka, JapanTaking people
- Tane ClinicOsaka, JapanTaking people
- Tane General HospitalOsaka, JapanTaking people
- Shiga University of Medical Science HospitalŌtsu, JapanTaking people
- JA Health Management Center SagamiharaSagamihara, JapanTaking people
- Kitasato University HospitalSagamihara, JapanTaking people
- Jichi Medical University Saitama Medical CenterSaitama, JapanTaking people
- Keijinkai Maruyama ClinicSapporo, JapanTaking people
- NTT East Sapporo HospitalSapporo, JapanTaking people
- Teine Keijinkai HospitalSapporo, JapanTaking people
- Tonan HospitalSapporo, JapanTaking people
- Okinawa Health Promotion FoundationShimajiri-gun Haebaru-cho, JapanTaking people
- Miraza Shinjuku Tsurukame ClinicShinjuku-ku, JapanTaking people
- Shinjuku Tsurukame ClinicShinjuku-ku, JapanTaking people
- Tokyo Women's Medical University HospitalShinjuku-ku, JapanTaking people
- Nihon University Itabashi Hospitaltabashi City, JapanTaking people
- KKR Takamatsu HospitalTakamatsu, JapanTaking people
- Mie Healthcare centerTsu, JapanTaking people
- Mie University HospitalTsu, JapanTaking people
- Wakayama Health Checkup Clinic KitadeWakayama, JapanTaking people
- Wakayama Medical University HospitalWakayama, JapanTaking people
- Public Interest Incorporated Foundation Yamagata Health Promotion OrganizationYamagata, JapanTaking people
- Yamagata University HospitalYamagata, JapanTaking people
- Yokohama City University Medical CenterYokohama, JapanTaking people
- Yokohama Rosai HospitalYokohama, JapanTaking people
- Oita University HospitalYufu, JapanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Cosomil, Inc.
- Trial code
- NCT07605819
- Record updated
- 27 October 2026
- Original description
This nationwide, multicenter, prospective, single-arm interventional feasibility study evaluates the Enzeavour Pancreatic Cancer assay in routine health checkups and cancer screening in Japan. Approximately 10,000 asymptomatic adults will be enrolled. Participants with an Enzeavour Score above 0.369 will undergo diagnostic work-up as clinically indicated. The primary outcome is pancreatic cancer detection rate within 12 months after the index blood draw, and the secondary outcome is positive predictive value.Read full original descriptionShow less
Pancreatic Cancer Screening Using Single-Molecule Enzyme Activity-Based Liquid Biopsy, Enzeavour: A Single-Arm Interventional Feasibility Study Protocol in Japan
This nationwide, multicenter, prospective, single-arm interventional feasibility study evaluates the Enzeavour Pancreatic Cancer assay in routine health checkups and cancer screening in Japan. Approximately 10,000 asymptomatic adults will be enrolled. Participants with an Enzeavour Score above 0.369 will undergo diagnostic work-up as clinically indicated. The primary outcome is pancreatic cancer detection rate within 12 months after the index blood draw, and the secondary outcome is positive predictive value.
Inclusion: Asymptomatic adults attending participating facilities for routine health checkups, organized cancer screening, or both; Able to understand the study procedures and provide written informed consent before enrollment.
Exclusion: Documented clinical history of pancreatic cancer; Any medical, psychological, or social condition that, in the opinion of the principal investigator at each participating site, makes participation inappropriate or compromises study integrity; Considered unable or unwilling to undergo any required diagnostic imaging modality (MRCP, EUS, or contrast-enhanced CT) after a positive index test result.